Cardiff Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Cardiff Oncology has a total shareholder equity of $49.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $62.9M and $13.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$57.67m |
| Equity | US$49.39m |
| Total liabilities | US$13.50m |
| Total assets | US$62.90m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XE7C's short term assets ($59.3M) exceed its short term liabilities ($12.5M).
Long Term Liabilities: XE7C's short term assets ($59.3M) exceed its long term liabilities ($979.0K).
Debt to Equity History and Analysis
Debt Level: XE7C is debt free.
Reducing Debt: XE7C had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XE7C has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: XE7C has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 19.5% each year.